# Disparities in Liver Transplantation Among Native Americans and Hispanic Individuals: Insights from a Southwest Region Center in the United States of America

**Authors:** Anandalakshmi Ponnaluri, Pooja Rangan, Pojsakorn Danpanichkul, Andrew Bell, Rebecca Postagate, Moises Ilan Nevah Rubin, Michael B. Fallon, Karn Wijarnpreecha

PMC · DOI: 10.3390/jcm15030953 · Journal of Clinical Medicine · 2026-01-24

## TL;DR

Native American and Hispanic patients face significant barriers to liver transplants and higher waitlist mortality compared to white patients.

## Contribution

This study identifies racial disparities in liver transplant access and outcomes in a U.S. Southwest region center.

## Key findings

- Native American and Hispanic patients had lower rates of liver transplant evaluation and listing compared to white patients.
- Waitlist mortality was significantly higher for Native American and Hispanic patients than for white patients.
- Financial barriers were more common among Native American and Hispanic patients.

## Abstract

Background: Liver transplantation (LT) is the definitive treatment for end-stage liver disease, yet racial and ethnic disparities persist across the LT continuum. This study investigated the patient-level and system-level barriers to LT and evaluated racial disparities in access and outcomes. Methods: We conducted a retrospective cohort study (2012–2022) at Banner University Medical Center, Phoenix, analyzing adult LT-referred, evaluated, waitlisted, and transplanted patients. Primary outcomes included mortality and LT barriers, assessed using competing-risk and Cox regression analyses. Results: Among 2877 LT-referred patients, 61% were Non-Hispanic White (NHW), 26% Hispanic, 8.8% Native American/Alaska Native (NA/AN), 3% Black, and 1% Asian. Compared with NHW patients, lower rates of LT evaluation and listing were observed among NA/AN (39% and 53%) and Hispanic patients (56% and 63%) versus NHW patients (51% and 64%). Patient-level financial barriers were more common among NA/AN (15.5%) and Hispanic (19.81%) individuals. Waitlist mortality was significantly higher for NA/AN (sub-distribution hazard ratio [SHR]: 5.26; p < 0.01) and Hispanic (SHR: 2.92, p < 0.02) patients than for NHW patients, whereas graft survival did not differ significantly by race. Conclusions: Marked racial and ethnic disparities exist in LT access and waitlist mortality, particularly among NA/AN and Hispanic patients. Targeted interventions addressing financial and systemic barriers are critical to ensuring equitable LT access and improving transplant outcomes.

## Linked entities

- **Diseases:** end-stage liver disease (MONDO:0100193)

## Full-text entities

- **Diseases:** end-stage liver disease (MESH:D058625)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12898143/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12898143/full.md

## References

35 references — full list in the complete paper: https://tomesphere.com/paper/PMC12898143/full.md

---
Source: https://tomesphere.com/paper/PMC12898143